The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Cemex SAB de CV

NYSE: CX
Last

(U.S.) $4.65

Today's change-0.37 -7.37%
Updated February 8 12:54 PM EST. Delayed by at least 15 minutes.
 

Cemex SAB de CV

NYSE: CX
Last

(U.S.) $4.65

Today's change-0.37 -7.37%
Updated February 8 12:54 PM EST. Delayed by at least 15 minutes.

Cemex SAB de CV down (U.S.)$0.37

Cemex SAB de CV is sharply lower today, dropping (U.S.)$0.37 or 7.37% to (U.S.)$4.65. Over the last five days, shares have gained 5.44%, but are down 16.52% for the last year to date. Shares have underperformed the S&P 500 by 40.89% during the last year.

Key company metrics

  • Open(U.S.) $4.91
  • Previous close(U.S.) $5.02
  • High(U.S.) $4.95
  • Low(U.S.) $4.61
  • Bid / Ask(U.S.) $4.65 / (U.S.) $4.66
  • YTD % change-16.52%
  • Volume9,396,755
  • Average volume (10-day)17,054,591
  • Average volume (1-month)13,736,338
  • Average volume (3-month)14,687,349
  • 52-week range(U.S.) $3.64 to (U.S.) $10.48
  • Beta2.48
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward64.03×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.07
Updated February 8 12:54 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1.44%

Cemex SAB de CV has a net profit margin of -1.44%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX1.53%Sector:Industry:

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue60,57259,38653,92153,147
Total other revenue--------
Total revenue60,57259,38653,92153,147
Gross profit20,56320,11918,43918,106
Total cost of revenue40,00939,26735,48235,041
Total operating expense54,75151,74851,99147,938
Selling / general / administrative13,27512,44012,21211,765
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total1,467424,2971,132
Operating income5,8217,6381,9295,209
Interest income (expense), net non-operating-4,085-4,016---3,937
Gain (loss) on sale of assets--------
Other--------
Income before tax-783,280-3,396941
Income after tax-6212,013-2,456-995
Income tax, total5431,267-9401,936
Net income-7321,759-2,498-1,399
Total adjustments to net income--------
Net income before extra. items-8251,759-2,498-1,548
Minority interest-205-254-42-553
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-8251,759-2,498-1,548
Inc. avail. to common incl. extra. items-7321,759-2,498-1,399
Diluted net income-7321,759-2,498-1,399
Dilution adjustment--------
Diluted weighted average shares40,39940,30425,64238,864
Diluted EPS excluding extraordinary itemsvalue per share-0.020.04-0.10-0.04
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.020.04-0.10-0.04